Popular Biotech News, Healthcare News and Pharma News

22:14 EDT 27th August 2015 | BioPortfolio

“Extreme Weight Loss”: When Jackie Sheds Her Guilt, She’s Ready to Begin Shedding Her Excess Weight at the University of Colorado Anschutz Health and Wellness Center

Denver, Colo. (PRWEB) August 21, 2015 The next episode of “Extreme Weight Loss” Season 5 follows Jackie (266 pounds; Denver, CO) through her emotional battle to overcome ...

FDA Approves Dexcom G5® Mobile Continuous Glucose Monitoring System

First and Only Fully Mobile CGM System Allows Adults and Children as young as 2 years old to Conveniently and Discreetly Monitor and Share Glucose Levels Dexcom, Inc., (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.S. Food and Drug Administration (FDA) has approved the Dexcom G5® M...

As CEO Transitions, Sanofi's Shantha Gears For New Phase

Dr Harish Iyer's move from the corner office at Shantha Biotechnics, part of the Sanofi Pasteur group, to the Bill and Melinda Gates Foundation appears rather seamless and quite in line with what the young former CEO of the Hyderabad-based firm had.....

GE Healthcare Life Sciences launches Capto Core 700 chromatography medium for viruses and other large biomolecules

High productivity alternative to group separation for intermediate purification and polishing,  offering higher sample loads and flow rates than gel filtration April 2nd 2012: GE Healthcare’s Capto Core 700 is a multimodal chromatography medium (resin) designed for intermediate purification and polishing of viruses and other large biomolecules. Capto Core 700 offers a range of pe...

Rheumatoid Arthritis products - Enbrel, Humira, Remicade, Simponi, Xeljanz, tofacitinib, Tabalumab, Fostamatinib, Secukinumab, Masitinib, Baricitinib, Sarilumab, Sirukumab

New market research, analysis and forecast reports for:Enbrel, Humira, Remicade, Simponi, Xeljanz, tofacitinib, Tabalumab, Fostamatinib, Secukinumab, Masitinib, Baricitinib, Sarilumab, SirukumabView latest publications at:http://www.bioportfolio.net/topic...

Screening Test for Stuttering

A screening test for children starting school that could accurately detect early signs of a persistent stutter is a step closer, British experts say. The Wellcome Trust team says a specific speech test accurately predicts whose stutter will persist into their teens. About 1 in 20 develops a stutter before age, but just one in 100 stutter as a teen and identifying these children has so far be...

Source BioScience opens new DNA sequencing facility in Tramore

3rd February 2014:  Source BioScience has expanded its market leading DNA sequencing service in Ireland with the official opening of its new laboratory in Tramore, County Waterford. The opening was conducted by John Perry TD, the Minister of State for Small Business, cutting the ceremonial ribbon alongside the Mayor of Tramore, Councillor Blaise Hannigan. The new laboratory is key to th...

Cyta Therapeutics

United BioPharma To Build $33.2 Million Plant In Taiwan

United BioPharma said it would build a $33.2 million antibody-production plant a home in Taiwan, expected to be operational by the end of 2016 and making 100 kilograms a year.

Biogen Idec and Sobi's Elocta MAA validated by EMA

The European Medicines Agency (EMA) has validated the marketing authorization application (MAA) of Biogen Idec and Swedish Orphan Biovitrum's (Sobi) Elocta (rFVIIIFc), a recombinant factor VIII Fc fusion protein product candidate to treat hemophilia ...

Ethicon Vaginal Mesh Lawsuit News: Third Federal Bellwether Trial Scheduled to Begin in March 2015, Bernstein Liebhard LLP Reports

The Firm is representing hundreds of women who have filed transvaginal mesh lawsuits that seek compensation for injuries and complications allegedly caused by pelvic mesh products marketed by Ethicon, Inc. and others. New York, New York (PRWEB) December 07, 2014 Thousands of vaginal mesh lawsuits (http://www.filevaginalmeshlawsuit.com/) filed against Ethicon, Inc. continue to move forward in a mu...

Osteomyelitis Global Clinical Trials Review, H2, 2014

Recently added to the BioPortfolio report store, Osteomyelitis Global Clinical Trials Review, H2, 2014 is a new report from GlobalData published on 2014-11-27. This 93-page report is available in PDF from $2500. Osteomyelitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Osteomyelitis Global Clinical Trials Review, H2, 2014" provides data on the Osteomyel...

Viekira OK'd; AbbVie prices under Gilead's Harvoni

Shares of AbbVie closed at $67.71 on 19 December, down 21 cents.

SullivanCotter Announces Open Participation for 2015 Compensation Surveys

Sullivan, Cotter and Associates, Inc. is pleased to announce that 2015 participation is now open for the following surveys: Manager and Executive Compensation in Hospitals and Health Systems Survey Physician Compensation and Productivity Survey Medical Group Compensation and Productivity S...

Redefining School Bullying in 2015, NoBullying Articles in the Spotlight Today

Redefining School Bullying in 2015, NoBullying Articles in the Spotlight Today http://nobullying.com/school-bullying-statistics-show-the-severity-of-the-problem/ London, UK (PRWEB) January 09, 2015 With the New Year finally here, NoBullying attempts to redefine the definitions and ramifications of School Bullying and what they mean in 2015, in a series of articles in the spotlight today. Bullyi...

Shelley L. Johnson, Honored Member of America’s Registry of Outstanding Professionals Has Been Selected as Bio of the Month of March 2015 and the Best of 2015

Farmingdale, NY, January 17, 2015 --(PR.com)-- Shelley L. Johnson is a Senior Analyst for Leidos Health. www.leidos.com She was born in Glendale, California. She attended Linfield College in Portland, Oregon where she earned her B.S.N. and the University of California at San Francisco where she earned her M.S.N. Leidos Health specializes in providing IT consulting services to the healthcare mark...

CareCentrix and Horizon Healthcare Services, Inc. Sign 5-Year Agreement to Provide Home Care Services for Millions of New Jersey Members

CareCentrix, the leader in managing patient care to the home, announced today that it has entered into a 5-year agreement with Horizon Healthcare Services, Inc., New Jersey’s oldest and largest health insurance company, to provide Homecare Benefit Management services. The agreement demonstrates the future of home-based transitional care and the central ...

Medical News Today: 'Soft micro-robots' could do biopsies, deliver drugs

Scientists are making self-folding microgrippers of stiff hydrogel embedded with iron nanoparticles for use as magnetically-guided, soft micro-robots for biopsy and drug delivery.

AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges

Long-term in vivo expression of a broad and potent entry inhibitor could circumvent the need for a conventional vaccine for HIV-1. Adeno-associated virus (AAV) vectors can stably express HIV-1 broadly neutralizing antibodies (bNAbs). However, even th...

Tecan launches Spark™ 10M reader at SLAS 2015

This all-new platform is designed to offer greater flexibility and increased productivity for cell biology and genomics customers. From microbiology research and cell-based assays to rapid DNA quantification, the Spark 10M delivers a combination of advanced capabilities and exceptional ease-of-use to simplify your daily work. At the heart of the Spark 10M are Tecan’s unique Fusion Optics whi...

Mount Sinai Health System and Bronx-Lebanon Hospital Center Health Care System Announce New Affiliation

The Mount Sinai Health System and Bronx-Lebanon Hospital Center Health Care System today announced a clinical collaboration aimed at providing superior health care to the residents of New York City’s northernmost borough. New York City, NY (PRWEB) February 24, 2015 The Mount Sinai Health System and Bronx-Lebanon Hospital Center Health Care System today announced a clinical collaboration aimed a...

Positive phase II data highlights benefits of Alcon's RTH258 for patients with neovascular (wet) age-related macular degeneration

Novartis International AG / Positive phase II data highlights benefits of Alcon's RTH258 for patients with neovascular (wet) age-related macular degeneration . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Phase II study met primary endpoint, demonstrating promising visual acuity gains in patients with n...

Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB

Medina, Ballabio and colleagues report that calcium release from the lysosome stimulates calcineurin, which dephosphorylates and activates TFEB. These findings reveal a central role for calcium signalling in autophagy and lysosome homeostasis.

Interview: Boehringer Ingelheim's Heidi Hunter on biosimilar originality, jousting and getting to market

German family-owned drug major Boehringer Ingelheim has been in the biosimilars business since the end…

AmeriSourceBergen Adds New Distribution Center in Australia

The new center represents AmerisourceBergen’s first facility erected specifically for clinical trial and commercial third-party logistics activities. Date:  Fri, 2015-02-13 (All day) ...

Deutsche Post-Aktie: Aktienkurs bildet robustes Wachstum hinreichend ab - J.P. Morgan erhöht Kursziel - Aktienanalyse

London - Deutsche Post-Aktienanalyse von Analyst Christopher Combe von J.P. Morgan: Christopher Combe, Analyst von J.P. Morgan, erhöht in einer aktuellen Aktienanalyse das Kursziel für die Aktie de...

Ocata Therapeutics Receives Regulatory Guidance from European Medicines Agency

Pivotal Clinical Trial Program Design for Stargardt’s Macular Degeneration Ocata Therapeutics, Inc. (“Ocata”; NASDAQ: OCAT), a leader in the field of regenerative ophthalmology, today announced that the company has received written formal guidance from the European Medicines Agency (EMA) related to the advancement of its Retinal Pigment Epitheliu...

Predicting drug metabolism: experiment and/or computation?

Efficient and reliable ways to predict drug metabolism early in the drug discovery process are important in reducing the risk of costly later-stage attrition. Schneider and colleagues summarize the state of the art in experimental and computational a...

Axcelon leverages bacterial cellulose expertise with Nanoderm launch

Axcelon Biopolymers, which plans to go public in the current quarter, has developed a sales and marketing plan with a leading wholesaler and its own sales team to gain maximum market share in Canada for its Nanoderm bacterial cellulose dressing to heal burns and wounds. “We also have ongoing discussions with local distributors in China […]

Gelesis, PureTech’s Weight-Loss Hopeful, Postpones IPO

Gelesis gobbled up some cash from private investors just a few months ago. But it looks like public investors don’t have the same type of appetite for the Boston startup’s hydrogel weight-loss pills. According to research firm Renaissance Capital...

German G-BA backs PTC Therapeutics’ Translarna for nmDMD

The benefit assessment by Germany's Federal Joint Committee (G-BA) indicated that US biotech firm PTC…

Malaria medicines: a glass half full?

Despite considerable advances in malaria medicines in the past 20 years, the global burden of malaria remains substantial. Moreover, continued emergence of drug resistance ensures that new antimalarials will be needed in the near future. Wells and co...

New requirements for temazepam

From 1 June 2015, prescriptions for temazepam will be required to meet full prescription requirements for Schedule 3 Controlled Drugs. Information on prescription requirements can be found in the Royal Pharmaceutical Society’s controlled drugs quick reference guide.

LION-HEART: IV Drug May Lower Hospitalization in CHF Patients

Intermittent administration of IV levosimendan lowered natriuretic-peptide levels, which translated into clinical improvements in patients with advanced, chronic HF, suggests new study from Spain. Heartwire from Medscape

Tippling Chimps Caught in the Act

Researchers in Africa observe chimpanzees stealing palm wine from villagers’ cups and imbibing the beverage.

Forxiga debuts in India at fraction of global prices

Forxiga, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, is available at INR43($0.67) per dose for 10mg in India – "competitively" priced with other innovative anti-diabetes drugs on the market.

Cambrooke Therapeutics Announces Launch of BetterMilk Lite

Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the introduction of BetterMilk Lite™, an advanced, lower calorie medical food formula containing its proprietary Glytactin™ with GMP for the dietary management of Phenylketonuria (PKU). Cambrooke Therapeutics was...

Anesthetist is sued after sedated patient recorded insults on phone

A Virginia anesthetist must pay $500 000 (£320 000; €450 000) in damages to a patient whose smartphone recorded her insulting and mocking him during a colonoscopy and deliberately giving him a false...

St. Jude Medical Announces Launch of the First International Trial to Compare OCT-Guided Stent Implantation to IVUS or Angiography-Guided PCI

Building on ILUMIEN I and ILUMIEN II, ILUMIEN III will compare St. Jude Medical’s OCT imaging to intravascular ultrasound and angiography to further shape the standard of care for cardiovascular patients St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of the ILUMIEN III clinical trial, a prospecti...

Likely new timelines for IDMP implementation revealed at industry webinar

The session, Assessing Authorities’ & Companies’ Progress Towards the IDMP, hosted by ProductLife Group & featuring expert commentators, set out a new plan of action for the life sciences industry for adopting the new global ISO standard Paris, France - July 7th, 2015 – A webinar hosted last week by life sciences outsourcing and consulting services specialist Produ...

FDA approves Galderma’s Epiduo Forte Gel

David SalazarGalderma Laboratories announced Thursday that the Food and Drug Administration had approved it Epiduo Forte Gel, an antibiotic-free daily treatment for acne vulgaris. read more

Nursing strategy drawn up for first time by CCGs

The first ever nursing strategy drawn up by clinical commissioning groups has been published in order to ensure nurses have a say in the shape of services.

Anthelio Healthcare Solutions Acquires Pyramid Healthcare Solutions, Positioning Anthelio As The Largest Independent Provider Of Health Information Management Services

Acquisition unites two HIM industry leaders, opening new markets and enhancing services for Anthelio and Pyramid customers Anthelio Healthcare Solutions, the largest independent provider of healthcare technology and services, today announced it has acquired Pyramid Healthcare Solutions, an Avantha Group company, a leading provider of Health I...

The 2015 BIO World Congress on Industrial Biotechnology Closes in Montreal - Event Sets New Record for Partnering Meetings

The 2015 BIO World Congress on Industrial Biotechnology, the largest international industrial biotech event, concluded today at the Palais des congrès de Montréal (Montreal Convention Center). This year’s Conference drew around 1,200 industry leaders from 725 companies, 50 countries and 37 states, as well as the District of Columbia. Organized b...

RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing

Proceeds will Further Strengthen RaNA’s Proprietary Platforms and Advance Lead Optimization and IND-Enabling Studies for Priority Programs RaNA Therapeutics, a leader in the discovery and development of a new class of medicines that target RNA to selectively activate protein expression within the body’s own cells, today announced the successful com...

Deal 2: Lupin snaps up Temmler's products

Lupin has announced its second acquisition on the trot – this time an asset purchase deal concerning Temmler Pharma GmbH & Co's specialty product portfolio in Germany.

Citizens Protest PIH Health Hospital – Downey’s Plan to Terminate Downey’s Hometown Emergency Doctors

Community action group, Downey Citizens for Quality Patient Care, urges hospital to keep quality healthcare local A grassroots coalition of Downey citizens and physicians is mobilizing to oppose controversial plans at the former Downey Regional Medical Center (now known as PIH Health Hospital – Downey) to replace a group of local doctors who have tre...

Renal physiology: The proximal tubule and albuminuria—at last a starring role

The constitutive uptake and degradation of filtered albumin by the proximal tubule has resulted in this process being relegated a passive player in albuminuria. Real-time intravital imaging of the rat kidney now describes a new paradigm in which the ...


Advertisement
 
Advertisement